The Perfusion Systems market was valued at US$ 1,044.75 million in 2018, registering at a CAGR of 3.8% from 2019 to 2027, according to a new research study conducted by The Insight Partners.
Significant Growth of Pharmaceutical and Biotechnology Industries is driving the market for perfusion systems over the forecast period.
The report highlights the trends prevalent in the global perfusion systems market and the factors driving the market along with those that act as deterrents to its growth.
The perfusion systems market by type is segmented into bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure driven perfusion systems, and small mammal organ perfusion systems. In 2018, the bioreactor perfusion systems segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, and scalability. Moreover, the microfluidic perfusion systems segment is anticipated to witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to increasing application of basic cell biology, molecular biological assays, tissue engineering, and systems biology.
Key factors driving the market are rising prevalence of cardiovascular diseases, significant growth of pharmaceutical and biotechnology industries, rising need for the organ transplantation, and rising cell based research activities. However, factors such as expensive organ transplant surgeries, and limited numbers of donors for organ transplant surgeries are likely to restrain the market growth to a certain extent.
Some of the prominent players operating in perfusion systems market are REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, Inc., XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), Getinge AB, TERUMO CORPORATION, LivaNova PLC, Sartorius AG, Harvard Bioscience, RAND, Sanisure (Sani-Tech West, Inc.), AutoMate Scientific, Inc., Jobst Technologies GmbH, APD (Advanced Perfusion Diagnostics), Spectrum Medical, Transonic Systems Inc, OrganOx, ISCHEMAVIEW, INC, and CESCO BIOENGINEERING CO., LTD. The market players are focused towards bringing new and innovative products to sustain their position in the market. For instance, in March 2018, Sartorius Stedim Biotech (Sartorius AG) launched ambr 250 high throughput (ht) perfusion, specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies. The developments performed by the companies are helping the market to grow in the coming years.
Perfusion Systems Market to 2027- Global Analysis and Forecasts by Type (Microfluidic Perfusion Systems, Small-Mammal Organ Perfusion Systems, Bioreactor Perfusion Systems, gravity or Pressure-Driven Perfusion Systems); Component (Perfusion Pumps, Oxygenators, Herat-Lung Machines, Monitoring Systems, Cannulas and Others) and Geography
Perfusion Systems Market Share & Size | Industry Growth 2027
Download Free Sample
The report segments the global perfusion systems market as follows:
Global Perfusion Systems Market - By Type
- Microfluidic Perfusion Systems
- Small-Mammal Organ Perfusion Systems
- Bioreactor Perfusion Systems
- Gravity or Pressure-Driven Perfusion Systems
Global Perfusion Systems Market - By Component
- Perfusion Pumps
- Oxygenators
- Heart-Lung Machines
- Monitoring Systems
- Cannulas
- Others
Global Perfusion Systems Market - By Geography
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific (APAC)
- Japan
- China
- India
- Australia
- South Korea
- Middle East & Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- South & Central America (SCAM)
- Brazil
- Argentina
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com